The Laboratory Corporation of America Holdings (LH) Shares Bought by Hahn Capital Management LLC, Report finds

The Laboratory Corporation of America Holdings (LH) Shares Bought by Hahn Capital Management LLC, Report finds

Several other large investors have also recently bought and sold shares of the stock. Concert Wealth Management Inc. raised its stake in Laboratory Corporation of America Holdings by 0.4% in the second quarter. Concert Wealth Management Inc. now owns 2,393 shares of the company’s stock valued at $313,000 after buying an additional 10 shares in the last quarter. Raymond James Trust N.A. raised its stake in shares of Laboratory Corporation of America Holdings by 0.4% in the third quarter. Raymond James Trust N.A. now owns 2,484 shares of the company’s stock valued at $341,000 after buying an additional 10 shares in the last quarter. MSI Financial Services Inc raised its stake in shares of Laboratory Corporation of America Holdings by 2.3% in the third quarter. MSI Financial Services Inc now owns 1,117 shares of the company’s stock valued at $154,000 after buying an additional 25 shares in the last quarter. Security National Bank of SO Dak raised its stake in shares of Laboratory Corporation of America Holdings by 0.3% in the second quarter. Security National Bank of SO Dak now owns 11,062 shares of the company’s stock valued at $1,441,000 after buying an additional 30 shares in the last quarter. Finally, Conning Inc. raised its stake in shares of Laboratory Corporation of America Holdings by 1.8% in the third quarter. Conning Inc. now owns 2,321 shares of the company’s stock valued at $319,000 after buying an additional 40 shares in the last quarter. 91.59% of the stock is currently owned by institutional investors and hedge funds.

Hahn Capital Management LLC boosted its stake in shares of Laboratory Corporation of America Holdings (NYSE:LH) by 60.6% during the third quarter, Holdings Channel reports. The institutional investor owned 232,654 shares of the company’s stock after buying an additional 87,770 shares during the period. Laboratory Corporation of America Holdings makes up approximately 2.9% of Hahn Capital Management LLC’s holdings, making the stock its 20th largest position. Hahn Capital Management LLC’s holdings in Laboratory Corporation of America Holdings were worth $29,161,000 as of its most recent filing with the SEC.

Laboratory Corporation of America Holdings (NYSE:LH) opened at 135.01 on Monday. The company’s 50-day moving average price is $132.27 and its 200 day moving average price is $132.96. The company has a market cap of $13.91 billion, a PE ratio of 21.41 and a beta of 0.94. Laboratory Corporation of America Holdings has a 52 week low of $102.42 and a 52 week high of $141.32.

Several equities research analysts have weighed in on LH shares. Robert W. Baird lowered Laboratory Corporation of America Holdings from an “outperform” rating to a “neutral” rating and set a $138.00 target price on the stock. in a research report on Monday, February 6th. Zacks Investment Research lowered Laboratory Corporation of America Holdings from a “hold” rating to a “sell” rating in a research report on Thursday, January 5th. Gabelli started coverage on Laboratory Corporation of America Holdings in a research report on Tuesday, October 25th. They issued a “buy” rating and a $180.00 target price on the stock. Deutsche Bank AG reaffirmed a “buy” rating and issued a $170.00 target price on shares of Laboratory Corporation of America Holdings in a research report on Wednesday, January 18th. Finally, Canaccord Genuity set a $140.00 target price on Laboratory Corporation of America Holdings and gave the stock a “buy” rating in a research report on Tuesday, January 17th. Six analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $146.60.

Laboratory Corporation of America Holdings Company Profile

Laboratory Corporation of America Holdings is a healthcare diagnostics company. The Company, together with its subsidiaries, is engaged in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Corporation of America Holdings (NYSE:LH).

Related posts

Leave a Comment